| Literature DB >> 35584986 |
Sixiang Cheng1,2, Yuxin Zhao1, Atipatsa Chiwanda Kaminga3,4, Xiaofen Wang1, Xinping Zhang5, Huilan Xu1.
Abstract
BACKGROUND: The 2019-nCoV (COVID-19) is spreading at an alarming rate worldwide. Therefore, it is currently one of the biggest global health challenges. This research review describes the differences in response to the coronavirus epidemic between countries across the world. In addition, an opinion that the experience of China in response against the epidemic would play an important role globally in the battle against the novel coronavirus has been discussed as well as the insufficient and delayed response by other countries.Entities:
Keywords: COVID-19; comparisions; cooperations; global response; suggestions
Mesh:
Year: 2022 PMID: 35584986 PMCID: PMC9127540 DOI: 10.1177/00469580221086142
Source DB: PubMed Journal: Inquiry ISSN: 0046-9580 Impact factor: 2.099
The websites’ information that collected about COVID-19.
| Website | Summary of Content Reported |
|---|---|
| Johns Hopkins University ( | Related to confirmed cases and deaths; total cases of nucleic acid test by date across countries |
| Ministry of industry and information technology of the People’s republic of China ( | Nucleic acid testability of China and Wuhan Report on the centralized nucleic acid test result, presented at the 78th press conference held at the COVID-19 prevention and control headquarters in Wuhan |
| Some countries’ responses and actions against the spread of COVID-19, after the first laboratory-confirmed cases emerged | |
| http://www.COVID-19 live | Some countries’ response and actions against the spread of COVID-19, after the first laboratory-confirmed cases emerged |
Figure 1.Cumulative death cases across countries (updated as of March 30, 2020).
Figure 2.Cumulative confirmed cases across countries (updated as of March 30,2020).
Comparisons of the main response actions against COVID-19 taken by different countries.
| Country | Date | Details of Public Health Intervention Measures Taken |
|---|---|---|
| China | December 27, 2019 (The first case was confirmed) | Hubei provincial hospital of integrated traditional Chinese and western medicine reported severe unidentified cases of pneumonia to the Center for disease control and prevention in Jianghan district, Wuhan. According to the analysis of the disease condition, treatment outcome, epidemiological investigation, and preliminary laboratory test, experts in Wuhan concluded that the above cases were viral pneumonia |
| China | December 30, 2019 | The Wuhan municipal health commission issued an urgent notice on the treatment of pneumonia of unknown cause to medical institutions in its jurisdiction. The national health commission (NHC) immediately organized the study and carried out the action as soon as it received the information |
| China | January 7, 2020 | President personally hosted a conference of the standing committee of the political bureau of the CPC central committee, where he put forward requirements on the prevention and control of the epidemic. Besides, he made a comprehensive study of the situation and promptly put forward the general demands of “strengthening confidence, working in the same boat, scientific prevention, and control, and taking precise measures” as an overall goal |
| China | January 20, 2020 | COVID-19 was included in the statutory report of class B infectious diseases and border health quarantine infectious diseases by the national health commission, which also made a timely release of information on the epidemic situation |
| China | January 23, 2020 10:00 | In Wuhan, according to the announcement of the epidemic prevention and control headquarters, the city’s buses, subways, ferries, and long-distance passenger transport were suspended, and the airport and railway station were temporarily closed |
Figure 3.Cumulative numbers of Nucleic Acid RT-PCR Test across countries (updated as of August 10, 2020).
The detailed nucleic acid testability of Wuhan and China.
| Location | Date | Number of People Tested |
|---|---|---|
|
| 2020/5/14 | |
| 2020/5/22 | 14,700 000 | |
| 2020/5/24 | 9,899,828 | |
| 2020/6/2 | 10 900 000 | |
|
|
| |
| 2020/03/01 | 1 260 000 | |
| 2020/06/01 | 3 780 000 | |
| 2020/7/30 | 4 840 000 |
Data source: China’s National Health Commission commissioner at the State Council joint prevention and control mechanism press conference (10 August 2020, date last accessed). And Ministry of Industry and Information Technology of the People’s Republic of China (www.miitbeian.gov.cn) and National Center for Clinical laboratories (https://www.nccl.org.cn/main). Date accessed: June 24, 2020.